Fluorotechnics suspended trading of its shares on the Australian Stock Exchange on October 1. Fluorotechnics announced in October that it sold Gel Company for $150,000 in cash. OpGen completed a $17 million Series B equity financing in September, led by jVen Capital. In October, NanoString Technologies appointed Barney Saunders, PhD, chief commercial officer. He previously […]

Company Announcements Rapidus news service reported in September that Ludesi AB, the provider of Redfin software for two-dimensional gel image analysis, went bankrupt. The largest shareholder was Innovation Capital. Integromics appointed Dr. Michael J. McManus as president and CEO in September. Previously, he led GenomeQuest’s corporate marketing, strategic alliances, product marketing and product development efforts. […]

For fiscal year 2009, Spain’s expenditure on R&D declined 0.8% to €14,582 million ($19,332 million), accounting for 1.38% of GDP. The business sector accounted for 51.9% of total R&D expenditure, a decline of 6.3% from 54.9%. Tertiary education comprised 27.8%, an increase of 3.1% from 26.7%. Public administration R&D expenditure made up 20.1%, increasing 9.5% […]

Company Announcements Avacta appointed Isogen Life Sciences as the distributor of its Optim 1000 in mainland Europe. Ghent University, the University of Antwerp and BioTools Europe partnered to create the European Center for Chirality, which opened on December 2. ASD named Mapping Solutions as a new distributor for the Middle Eastern remote-sensing market. Centice entered […]

In an attempt to revamp science at its universities and silence critics who claim inadequate funding for basic research, particularly at the Russian Academy of Sciences (RAS), Russia’s government has implemented several programs to encourage more university research other than RAS. The programs include a “national research university” program, which now includes 40 universities. Other […]

According to a recently released National Bureau of Statistics report on R&D resources, China’s R&D spending is growing quickly and is slated to reach 2% of GDP in 2010. In 2009, China’s total R&D spending was CNY 580 billion ($85 billion), or 1.7% of GDP, which represents an average annual increase of 23% since 2000, […]

A Tufts Center for the Study of Drug Development report indicates that pharmaceutical companies are increasingly using personalized medicine to develop drugs. According to Christopher-Paul Milne, associate director at the center, 12%–50% of drugs in development rely on a personalized medicine approach, which often involves tests to indicate which patients are most likely to experience […]

The National Institute of Health’s (NIH) Scientific Management Review Board (SMRB) has voted 12–1 to create a new translational medicine center that would combine several programs to try to get drugs to the market faster. The center would be the base for the $500 million Clinical and Translational Science Awards (CTSAs) program. This may jeopardize […]

Though the US chemical industry rebounded in 2010 after two years of declines, it still lags in growth, said American Chemistry Council (ACC) economists. Overall US chemical production volumes are estimated to increase by 3.1% in 2010 and 3.0% in 2011, compared with declines of 4.7% and 4.5% in 2008 and 2009, respectively. Excluding pharmaceuticals, […]